AbCellera Results Presentation Deck

Q1 2023 BUSINESS UPDATE COPYRIGHT © ABCELLERA 9 PARTNER-INITIATED PROGRAMS. Helping partners reach their next value inflection point. AbCellera was a founding partner in Abdera, who just announced $142M in financing. First program program started in March 2021, and Abdera announced it plans to file an IND in 2024 for its first clinical candidate, a radiopharmaceutical for the treatment of cancer. First IND anticipated in 2024 Abdera Therapeutics

View entire presentation